[Current Developments in the Medical Treatment of Advanced Urothelial Carcinoma of the Bladder.]

This article focuses on important clinical trials and developments of the last two years, with a review of literature and proceedings of the relevant meetings (ASCO, GU-ASCO, EAU, AUA). The general benefit of perioperative chemotherapy is confirmed. Chemotherapy with Gemcitabin/Cisplatin remains the therapy of choice in the palliative setting. So far, targeted therapies did not show convincing results.
PMID: 24500963 [PubMed - as supplied by publisher]

Source: Aktuelle Urologie - January 1, 2014 Category: Urology & Nephrology Authors: Schmid SC, Gschwend JE, Retz M, für die Arbeitsgemeinschaft Urologische Onkologie der Deutschen Krebsgesellschaft (AUO) Tags: Aktuelle Urol Source Type: research